Korean J Hepatol.  2008 Mar;14(1):102-107. 10.3350/kjhep.2008.14.1.102.

A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia

Affiliations
  • 1Korea University Medical College Guro Hospital, Department of Internal Medicine, Seoul, Korea. je_yeon@hotmail.com
  • 2Korea University Medical College Guro Hospital, Department of Pathology, Seoul, Korea.
  • 3Korea University Medical College Ansan Hospital, Department of Laboratory Medicine, Ansan, Korea.

Abstract

Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge, there are only a few published reports of the simultaneous occurrence of cholestatic hepatitis and pure red cell aplasia. Here we report a patient with simultaneous severe cholestatic hepatitis and pure red cell aplasia associated with ticlopidine. Although these adverse effects are rare, periodic hematological and liver function tests are recommended after starting ticlopidine.

Keyword

Ticlopidine; Pure red cell aplasia; Hepatitis, Drug-Induced; Adverse effect

MeSH Terms

Acute Disease
Cholestasis/*chemically induced/diagnosis/etiology
Female
Hepatitis, Toxic/*diagnosis/pathology
Humans
Liver Function Tests
Middle Aged
Platelet Aggregation Inhibitors/*adverse effects
Red-Cell Aplasia, Pure/*chemically induced/diagnosis/pathology
Ticlopidine/*adverse effects
Full Text Links
  • KJHEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr